IMPACT OF SINUSITIS IN CYSTIC-FIBROSIS

被引:108
作者
RAMSEY, B
RICHARDSON, MA
机构
[1] CHILDRENS HOSP & MED CTR,DIV OTOLARYNGOL,SEATTLE,WA 98105
[2] UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195
[3] UNIV WASHINGTON,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,SEATTLE,WA 98195
关键词
SINUSITIS; CYSTIC FIBROSIS;
D O I
10.1016/0091-6749(92)90183-3
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The cause of cystic fibrosis has been determined to be faulty ionic transport of chloride across the apical membrane of epithelial cells lining exocrine glands. The subnormal ionic transport leads to dehydration of extra cellular fluids and the development of thickened inspissated mucous secretions. The vast majority of patients with cystic fibrosis develop sinus disease with panopacification of the sinuses present in 90% to 100% of patients older than 8 months of age. Indications for surgical management of sinusitis in children with cystic fibrosis include (1) chronic nasal obstruction with mouth breathing, (2) chronic purulent draining nasal secretions unresponsive to medical treatment, and (3) persistent headaches thought to be related to sinusitis. Operative therapy is based on computerized tomographic scan findings and can be performed endoscopically. Postoperative management is critical for ensuring successful surgical results. Antibiotics, topical steroids, and cleansing of the surgical fields must be performed on a regular basis to ensure adequate healing. The impact of sinusitis on the cystic fibrosis population is significant. Approximately 20% of patients will eventually require surgical treatment of their sinuses. Chronic sinusitis may cause deformities of the external nasal skeleton, a loss of the sense of smell, and headaches.
引用
收藏
页码:547 / 552
页数:6
相关论文
共 50 条
  • [21] CONGENITAL HYPOTHYROIDISM AND CYSTIC-FIBROSIS
    DEPASSE, C
    CHANOINE, JP
    CASIMIR, G
    VANVLIET, G
    ACTA PAEDIATRICA SCANDINAVICA, 1991, 80 (10): : 981 - 983
  • [22] HETEROZYGOTE SCREENING FOR CYSTIC-FIBROSIS
    BROCK, DJH
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1995, 3 (01) : 2 - 13
  • [23] POPULATION SCREENING IN CYSTIC-FIBROSIS
    BURN, J
    MAGNAY, D
    CLABER, O
    CURTIS, A
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1993, 86 : 2 - 6
  • [24] LAPAROSCOPIC CHOLECYSTECTOMY AND CYSTIC-FIBROSIS
    HORGAN, PG
    NEARY, P
    REID, S
    TRAYNOR, O
    MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 1994, 3 (04): : 211 - 212
  • [25] PHARMACOLOGICAL MANAGEMENT OF CYSTIC-FIBROSIS
    WALLACE, CS
    HALL, M
    KUHN, RJ
    CLINICAL PHARMACY, 1993, 12 (09): : 657 - 674
  • [26] SOMATOSENSORY DYSFUNCTION IN CYSTIC-FIBROSIS
    STALEY, K
    IRAGUI, VJ
    EUROPEAN NEUROLOGY, 1991, 31 (02) : 77 - 81
  • [27] GROWTH DYNAMICS IN CYSTIC-FIBROSIS
    GRECO, L
    SANTAMARIA, F
    SALVATORE, D
    DERITIS, G
    ACTA PAEDIATRICA, 1993, 82 (03) : 254 - 260
  • [28] THE BIOCHEMICAL DEFECT IN CYSTIC-FIBROSIS
    CUTHBERT, AW
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1992, 85 : 2 - 5
  • [29] CYSTIC-FIBROSIS GENE UPDATE
    CUTHBERT, A
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1994, 87 : 2 - 4
  • [30] ANTIMICROBIAL TREATMENT IN CYSTIC-FIBROSIS
    DEMONTALEMBERT, M
    BERCHE, P
    LENOIR, G
    ANNALES DE PEDIATRIE, 1991, 38 (08): : 523 - 528